Prevention of variceal rebleeding by propranolol: Can “nonresponders” be identified?
- Read more about Prevention of variceal rebleeding by propranolol: Can “nonresponders” be identified?
A. K. Burroughs – 1 November 1986 – Between October, 1981 and December 1983, 46 consecutive unselected cirrhotic patients who had been admitted for variceal hemorrhage were assigned to propranolol for the prevention of variceal rebleeding and followed for a mean period of 13.3 months (ranges: 1 day, 45 months). At the time of inclusion, 87 p. 100 of patients had alcoholic cirrhosis: ascites was present in 43 p. 100, jaundice in 43 p. 100 and encephalopathy in 33 p. 100 of cases.